Skip to content

Architect 7D55-22

by Abbott

Ref 07D5522

Architect 7D55-22 (07D5522) is an in vitro diagnostic device (EU IVDR Class B; FDA Class II; FDA product code CJE, Nitrophenylphosphate, Alkaline Phosphatase or Isoenzymes) made by Abbott, registered in EUDAMED on 23 Aug 2026 (Basic UDI-DI 038074ARD0755L2) and listed in FDA GUDID since 30 May 2017 (UDI-DI 00380740150891), active as of 23 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number038074ARD0755L2 Basic UDI-DI 00380740150891UDI-DIDate23 Aug 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00380740150891 UDI-DI Date30 May 2017ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Alkaline Phosphatase
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 038074ARD0755L2 registered 23 Aug 2026 Active
  • FDA GUDID UDI-DI 00380740150891 listed 30 May 2017 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00380740150891
  2. Registered EUDAMED 038074ARD0755L2

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Architect
Generic name
Total alkaline phosphatase (ALP) IVD, reagent
Device name
ARCHITECT Alkaline Phosphatase
Model / Ref / Catalog
07D5522, 7D55-22
Primary DI / UDI-DI
00380740150891
Basic UDI-DI
038074ARD0755L2
FDA product code
CJE
EMDN code
W01010105 Alkaline phosphatase - total
GMDN term
Total alkaline phosphatase (ALP) IVD, reagent
Device class
Class B EUDAMED
Class II GUDID
Regulation number
862.1050
EU registration type
Standard device
EU market of registration
Ireland
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
07D5522
GUDID
7D55-22
Device classEUDAMED
Class B
GUDID
Class II

Device class is stated on each registry's own scale: Class B in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under ALKALINE PHOSPHATASE - TOTAL.

Other devices from Abbott

See all devices from Abbott →

Properties

  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (19, all answered No)